Search Results
(3R,4S)-tert-Butyl 4-hydroxy-3-methylpiperidine-1-carboxylate 1g | 97%
BLD Pharmatech Ltd.
(3R,4S)-tert-Butyl 4-methoxy-3-methylpiperidine-1-carboxylate 1g | 95%
BLD Pharmatech Ltd.
(3R,4S)-Tetrahydrofuran-3,4-diamine dihydrochloride 1g | 95%
BLD Pharmatech Ltd.
(3R,4S)-Tetrahydrofuran-3,4-diamine dihydrochloride 5g | 95%
BLD Pharmatech Ltd.
(3R,4S)-Tetrahydrofuran-3,4-dicarboxylic acid 1g | 97%
BLD Pharmatech Ltd.
(3R,4S)-Tofacitinib 1mg | ≥98%
CSNpharm
(3R,4S)-Tofacitinib is an isomer of tofacitinib, an inhibitor of JAK3 with IC50 of 1 nM, 20- to 100-fold less potent against JAK2 and JAK1.
More Information Supplier Page(3R,4S)-Tofacitinib Please inquire | >98%
BOC Sciences
(3R,4S)-Tofacitinib is a less active enantiopure stereoisomer of the JAK3 inhibitor Tofacitinib.
More Information Supplier Page(3R,4S)-Tofacitinib 5mg | ≥98%
CSNpharm
(3R,4S)-Tofacitinib is an isomer of tofacitinib, an inhibitor of JAK3 with IC50 of 1 nM, 20- to 100-fold less potent against JAK2 and JAK1.
More Information Supplier Page(3R,4S)-Tofacitinib 5mg | Purity Not Available
Selleck Chemicals
(3R,4S)-Tofacitinib is a less active enantiomer of Tofacitinib and a first-in-class inhibitor of JAK3 with an IC50 of 1 nM. It is highly efficacious in treating rheumatoid arthritis (RA).
More Information Supplier Page(3R,4S)-Tofacitinib 25mg | Purity Not Available
Selleck Chemicals
(3R,4S)-Tofacitinib is a less active enantiomer of Tofacitinib and a first-in-class inhibitor of JAK3 with an IC50 of 1 nM. It is highly efficacious in treating rheumatoid arthritis (RA).
More Information Supplier Page

